Shots: The approval is based on the P-III trial that evaluates Ultomiris (q4w/q8w) vs Soliris in children & adolescents aged ≤18yrs. with PNH The interim result showed that the therapy […]readmore
Tags : Paroxysmal Nocturnal Haemoglobinuria